About: pfizer
Pharma industry improved since before pandemic say patient groups
Since the pandemic, the public image of big pharma companies such as Sanofi, Pfizer, AstraZeneca, and Bayer has improved, according to a survey of 2,150 patient groups worldwide.
EU defends IP waiver compromise amid pressure on India, South Africa to reject it
A broad international platform of activists, unions and experts has urged India and South Africa to reject the leaked compromise on intellectual property rights on COVID-19 vaccines, which the European Commission considers the ‘most promising path’ to sort out the issue.
COVID vaccine tracker should be applied to 40 other vaccines, says ECDC
EU countries need to further develop tracking tools to monitor vaccine rates, the director of the EU's infectious disease agency (ECDC) said, amongst talks of centring the role of digital health in preventative care.
EU watchdog accuses Commission of maladministration over texts to Pfizer CEO
The European Commission's denial of access to text messages between Commission President Ursula von der Leyen and Pfizer CEO Albert Bourla amounts to ‘maladministration’, the EU Ombudsman found.
EMA gives green light for EU’s first oral COVID-19 antiviral treatment
The European Medicines Agency (EMA) has recommended the conditional marketing authorisation of Pfizer's new COVID antiviral drug Paxlovid, with official authorisation by the European Commission expected imminently.
US-Germany rift could scupper vaccine patent waiver
A bold US bid to waive patents on much-needed coronavirus vaccines was strongly opposed by Germany on Thursday (6 May), threatening to derail the proposal that requires the consensus of World Trade Organisation members to pass.
Commission concerned about COVID vaccines black market
European Commission President Ursula von der Leyen has warned member states that getting supplies of COVID vaccines from illicit trade entails considerable risks for human health.